Literature DB >> 10562

Treatment of angina pectoris. Pharmacologic approaches.

W S Aronow.   

Abstract

The short-acting nitrite sublingual nitroglycerin is the cornerstone of drug treatment of angina pectoris. It is most useful when given two to three minutes before activity that may precipitate an anginal attack. If disabling angina persists despite medical management and there is no contraindication, the beta-adrenergic blocking agent propranolol should be tried before coronary artery surgery is considered. Newer bera-adrenergic blocking agents do not appear to be more effective than propranolol. Digitalis may be beneficial in patients with congestive heart failure or with cardiac arrhythmias responsive to digitalis and in some patients with radiographic evidence of left ventricular enlargement or with nocturnal angina resulting from increased left ventricular end-diastolic volume. If bypass graft surgery is done, medical management must be continued postoperatively.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 10562     DOI: 10.1080/00325481.1976.11714477

Source DB:  PubMed          Journal:  Postgrad Med        ISSN: 0032-5481            Impact factor:   3.840


  1 in total

1.  Improved physical performance as a therapeutic objective in patients with angina.

Authors:  A S Ling; J T Groel
Journal:  Br J Clin Pharmacol       Date:  1979       Impact factor: 4.335

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.